[{"Assets_0_FY_USD":34345000.0,"CommonStockSharesOutstanding_0_FY_shares":9713042.0,"NetIncomeLoss_1_FY_USD":-4202000.0,"NetIncomeLoss_4_FY_USD":-18603000.0,"StockholdersEquity_0_FY_USD":31327000.0,"Assets_0_Q1_USD":30784000.0,"CommonStockSharesOutstanding_0_Q1_shares":9713042.0,"NetIncomeLoss_1_Q1_USD":-4928000.0,"StockholdersEquity_0_Q1_USD":26734000.0,"Ticker":"KALV","CIK":"1348911","name":"KALVISTA PHARMACEUTICALS, INC.","OfficialName":"KalVista Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20170430","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339433230.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170914"}]